ERBB2 and breast adenocarcinoma: No radiological responses were noted, but two patients (one with HER2 3+ gastroesophageal adenocarcinoma and one with HER2 2+ breast adenocarcinoma) demonstrated prolonged disease stabilization lasting ≥4 months [102].